OpenEye is proud to be a sponsor for AWS re:Invent 2016, the largest gathering to date of the global Amazon Web Services community. Stop by and see us at Booth #2235.
We will also be presenting the following talk:
Automating Computational Infrastructure at Scale for Scientific Workloads (ENT213) Anthony Nicholls, CEO Jharrod LaFon, Chief Cloud Engineer Craig Bruce, Scientific Software Development Manager
Nov 30, 2016 • 11-12 pm (PT) Location: The Venetian Resort
Large-scale computation is an important aspect of modern drug design. Fortune 500 pharmaceutical companies are increasingly using cloud-based computation. But the value of the cloud isn't limited to running compute-intensive tasks quickly. It also enables company-wide collaboration: the ability to build, modify, share, and manage versions and evaluate computational methods. Because of their size, the need to work across multiple divisions, and their abundance of legacy software, large pharmaceutical companies, such as Pfizer, Inc., find it difficult to achieve this level of collaboration. OpenEye's AWS-native platform, Orion, and its workflow engine, Floe, provide companies like Pfizer tools for developing innovative approaches to company-wide collaboration and data sharing. This session introduces Floe, and shows IT managers and professionals how to dramatically increase the impact of cloud-based computation within their organizations.
IMPORTANT: Please note if you are planning to attend the talk, you must register for AWS re:Invent AND reserve your seat at the session ahead of time at the link below. If you are undecided, please reserve a seat regardless, as tickets will sell out prior to the event.